A new publication on difelikefalin was released on July 31, 2026. The article, titled "Real-world effectiveness and safety of difelikefalin for chronic kidney disease-associated pruritus: a systematic review," appeared in the journal Renal Failure. Difelikefalin is an approved compound referenced in this systematic review context. The publication is identified under PubMed ID 42576770. This entry represents a systematic review format, which compiles existing real-world data on the compound's use in patients with chronic kidney disease-associated pruritus. No specific findings, outcomes, or data points from the review are detailed here. Readers interested in the full scope of the review's methodology and conclusions should consult the original source. For additional background on difelikefalin, including its regulatory status and general profile, readers can refer to the compound overview.
Difelikefalin Publication: Systematic Review of Real-World Use in CKD Pruritus
See the full difelikefalin overview
Source: https://pubmed.ncbi.nlm.nih.gov/42576770/